BILLIE LANCASTER: Open Payments
NPI 1598278566 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 12 payments from 10 companies in 2025. Trend: 2023 $36 · 2024 $126 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $62 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 1 | $36 |
| Verona Pharma, Inc. | 1 | $25 |
| Insmed, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Grifols USA, LLC | 1 | $21 |
| Viatris Specialty LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: DUPIXENT, UPTRAVI, WINREVAIR, Ohtuvayre, Arikayce, Prolastin-C Liquid, CAPVAXIVE, YUPELRI.
Industry payments across TN — which companies pay providers there.
